Rho iso-alpha acids from hops inhibit the GSK-3/NF-B pathway and reduce inflammatory markers associated with bone and cartilage degradation

Abstract

Background. Rho iso-alpha acids (RIAA) from hops have been shown to have anti-inflammatory properties. To understand the mechanisms, we evaluated the effect of RIAA in cell signaling pathways and inflammatory markers using various in vitro models. We also investigated their therapeutic effect in mice with collagen-induced arthritis. Methods. The LPS-stimulated RAW 264.7 macrophages were used to evaluate the effect of RIAA on the NF-B and MAPK signaling pathways; phosphorylation of ERK1/2, p38 and JNK was assessed by western blotting and NF-B binding by electrophoretic mobility shift assays. Effect on the NF-B activity was evaluated by the luciferase reporter assays in LPS-stimulated RAW 264.7 cells. GSK-3/ kinase activity was measured in cell-free assays. The inhibitory effect of RIAA on inflammatory markers was assessed by measuring nitric oxide in LPS-stimulated RAW 264.7 cells, RANKL-mediated TRAP activity in transformed osteoclasts, and TNF-/IL-1-mediated MMP-13 expression in SW1353 cells. Mice with collagen-induced arthritis were fed with RIAA for 2 weeks. Symptoms of joint swelling, arthritic index and joint damage were assessed. Results. RIAA selectively inhibited the NF-B pathway while having no effect on ERK1/2, p38 and JNK phosphorylation in LPS-stimulated RAW 264.7 cells. RIAA also inhibited GSK-3/ kinase activity and GSK-3 dependent phosphorylation of -catenin in RAW 264.7 cells. In addition, RIAA inhibited NF-B-mediated inflammatory markers in various cell models, including nitric oxide in LPS-stimulated RAW 264.7 cells, RANKL-mediated TRAP activity in transformed osteoclasts, and TNF-/IL-1-mediated MMP-13 expression in SW1353 human chondrosarcoma cells. Finally, in a mouse model of collagen-induced arthritis, RIAA ameliorated joint damage as evidenced by significant reduction of the arthritis index and histology score; at 250 mg/kg-body weight, RIAA had efficacy similar to that of 20 mg/kg-body weight of celecoxib. Conclusion. RIAA may have potential as an anti-inflammatory therapeutic. © 2009 Konda et al; licensee BioMed Central Ltd.